omeprazole has been researched along with Esophageal Perforation in 2 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Esophageal Perforation: An opening or hole in the ESOPHAGUS that is caused by TRAUMA, injury, or pathological process.
Excerpt | Relevance | Reference |
---|---|---|
"Eight patients (17%) with relapse of dysphagia were referred to laparoscopic Heller myotomy with no surgical complication." | 1.36 | Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results. ( Dolina, J; Hep, A; Kroupa, R; Matyasova, Z; Mrazova, J; Novotny, I; Prokesova, J; Sedmik, J; Valek, V, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kroupa, R | 1 |
Hep, A | 1 |
Dolina, J | 1 |
Valek, V | 1 |
Matyasova, Z | 1 |
Prokesova, J | 1 |
Mrazova, J | 1 |
Sedmik, J | 1 |
Novotny, I | 1 |
Ardengh, JC | 1 |
Domene, CE | 1 |
Valiati, LH | 1 |
Morrell, AC | 1 |
2 other studies available for omeprazole and Esophageal Perforation
Article | Year |
---|---|
Combined treatment of achalasia - botulinum toxin injection followed by pneumatic dilatation: long-term results.
Topics: Adult; Aged; Aged, 80 and over; Botulinum Toxins, Type A; Catheterization; Cohort Studies; Combined | 2010 |
Conservative management of esophageal perforation following obesity surgery.
Topics: Anti-Bacterial Agents; Ceftriaxone; Enteral Nutrition; Enzyme Inhibitors; Esophageal Perforation; Fe | 2006 |